Ans T. van der Ploeg

Ans T. van der Ploeg is a Full Professor in the Department of Pediatrics at Erasmus MC, a leading academic medical center in the Netherlands. Her work is centered on rare metabolic and neuromuscular disorders, particularly Pompe disease (Glycogen Storage Disease Type II), where she has made significant clinical and research contributions.

Her research interests include:

• Enzyme Replacement Therapy
• Lysosomal Storage Diseases
• Pompe Disease Pathophysiology and Management
• Patient Quality of Life and Fatigue
• Real-World Evidence in Rare Diseases
• Neuromuscular and Pediatric Metabolic Disorders

Recent publications highlight her leadership in clinical trials, patient-centered outcomes, and international collaborations, especially within the ERN EURO-NMD network. Her work spans high-impact journals such as The Lancet Neurology and Orphanet Journal of Rare Diseases.

The trends in her recent articles show a consistent focus on:

• Improving therapeutic delivery (e.g., home infusion)
• Evaluating long-term treatment outcomes
• Understanding patient-reported outcomes
• Advocating for robust real-world data in rare disease regulation
• Collaborative European research initiatives
• Clinical guidelines and awareness among healthcare providers

While no specific scientific awards are listed in the provided text, her extensive publication record (276 research outputs) and supervision of 34 research works reflect significant recognition and academic leadership.

She has supervised numerous students and early-career researchers, contributing to training in rare disease medicine. Although specific grants are not mentioned, her involvement in multi-center clinical trials and European networks suggests substantial grant funding and collaborative support. Her work is deeply integrated into clinical practice and policy development for rare diseases.

She is actively involved in research teams focusing on metabolic disorders and participates in international consortia such as ERN EURO-NMD, facilitating cross-border collaboration to improve diagnosis, treatment, and patient support for rare neuromuscular conditions.